Takeda Pharmaceutical
TAK
#451
Rank
NZ$94.37 B
Marketcap
NZ$29.55
Share price
1.06%
Change (1 day)
22.80%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): NZ$0.28 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.73 Billion. In 2025 the company made an earning of NZ$5.70 Billion, an increase over its 2024 earnings that were of NZ$3.82 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.28 B-95.07%
2025 NZ$5.70 B49.03%
2024 NZ$3.82 B-2.41%
2023 NZ$3.92 B-28.14%
2022 NZ$5.45 B-40.9%
2021 NZ$9.23 B78.24%
2020 NZ$5.18 B246.1%
2019 NZ$1.49 B-48.79%
2018 NZ$2.92 B-23.64%
2017 NZ$3.82 B21.7%
2016 NZ$3.14 B-253.01%
2015 -NZ$2.06 Billion-159.65%
2014 NZ$3.44 B13%
2013 NZ$3.04 B2.46%
2012 NZ$2.97 B-57.05%
2011 NZ$6.92 B-10.49%
2010 NZ$7.74 B-3.99%
2009 NZ$8.06 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.55 B 9,308.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.07 B 5,616.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.16 B 3,735.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.58 B 3,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.13 B 2,673.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$22.55 B 4,663.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.17 B 3,525.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.36 Billion-386.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.13 B 140.37%๐Ÿ‡ฎ๐Ÿ‡ณ India